{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:13:50Z","timestamp":1782285230380,"version":"3.54.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The purpose of this study was to report the indications and outcomes of oral cyclosporine A (oCsA) use in vernal keratoconjunctivitis (VKC) and to assess its effect on corticosteroid use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective review of VKC cases included patients who were prescribed oCsA. Data on clinical characteristics, demographic profile, and treatment were collected. An acute episode was defined as one requiring oral\/topical corticosteroids. The outcome measure was the difference in the number of acute episodes before and after oCsA use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The study included 27 cases (54 eyes) of VKC from 2016 to 2024. The median age was 20 years. Thirty eyes had sequelae due to VKC, the most common of which was limbal stem cell deficiency (46%). The median duration of follow-up was 11 months. Indications for oCsA were recalcitrant disease (23\/27, 85%) and severe active allergy in steroid-induced glaucoma\/steroid responders (4\/27, 15%). None of the cases experienced progression of sequelae with oCsA use. Forty-two acute episodes were observed before oCsA initiation over 403 person-months, which reduced to 10 episodes over 250 person-months with oCsA use. Without oCsA use, the odds of developing an acute exacerbation of the ocular allergy were 2.6 times (95% confidence interval: 1.3\u20135.2) higher compared with that with oCsA usage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Oral cyclosporine reduces corticosteroid use in VKC and can be considered in recalcitrant disease or in eyes with steroid-induced glaucoma and active allergy. Oral cyclosporine significantly reduced the risk of acute exacerbations, proving to be an effective modality for controlling inflammation in VKC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000003786","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T09:00:30Z","timestamp":1736499630000},"page":"1078-1083","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Oral Cyclosporine in Vernal Keratoconjunctivitis: Indications, Outcomes, and Effect on Corticosteroid Use"],"prefix":"10.1097","volume":"44","author":[{"given":"Anahita","family":"Kate","sequence":"first","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Vijayawada, Andhra Pradesh, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haritha Goud","family":"Tallapelly","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Vijayawada, Andhra Pradesh, India;"},{"name":"Academy for Eye Care Education, LV Prasad Eye Institute, Hyderabad, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Jain","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Hyderabad, Telangana, India; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumari","family":"Yukti","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Vijayawada, Andhra Pradesh, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-5003","authenticated-orcid":false,"given":"Sayan","family":"Basu","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Hyderabad, Telangana, India; and"},{"name":"Centre for Ocular Regeneration (CORE), Prof. Brien Holden Eye Research Centre (BHERC), LV Prasad Eye Institute, Hyderabad, Telangana, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"882240","DOI":"10.3389\/fmed.2022.882240","article-title":"Diagnosis, management, and treatment of vernal keratoconjunctivitis in asia: recommendations from the management of vernal keratoconjunctivitis in asia expert working group","volume":"9","author":"Mehta","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bjophthalmol-2019-313988","article-title":"Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis","volume":"104","author":"Senthil","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/ICO.0b013e3181cbf9d3","article-title":"Vernal keratoconjunctivitis with limbal stem cell deficiency","volume":"30","author":"Sangwan","year":"2011","journal-title":"Cornea"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/08820538.2021.1966059","article-title":"Systemic immunosuppression in cornea and ocular surface disorders: a ready reckoner for ophthalmologists","volume":"37","author":"Kate","year":"2022","journal-title":"Semin Ophthalmol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0301-4738.179727","article-title":"Systematic approach to managing vernal keratoconjunctivitis in clinical practice: severity grading system and a treatment algorithm","volume":"64","author":"Gokhale","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4103\/IJO.IJO_2818_22","article-title":"Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease","volume":"71","author":"Kate","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/ACI.0000000000000675","article-title":"Allergic conjunctivitis in children: current understanding and future perspectives","volume":"20","author":"Vazirani","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0301-4738.95878","article-title":"Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis","volume":"60","author":"Gokhale","year":"2012","journal-title":"Indian J Ophthalmol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/ACI.0b013e3282efb726","article-title":"Clinical grading of vernal keratoconjunctivitis","volume":"7","author":"Bonini","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1080\/09273948.2022.2103830","article-title":"Effect of anti-allergic therapy on quality of life in children with allergic conjunctivitis and their parents","volume":"31","author":"Fan","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/ACI.0000000000000776","article-title":"Psychosocial impact of ocular surface allergic inflammatory disorders","volume":"21","author":"Mendelson","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/bjd\/ljad281","article-title":"Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial","volume":"189","author":"Flohr","year":"2023","journal-title":"Br J Dermatol"},{"issue":"suppl 48","key":"R13-20250804","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2133.1996.tb00704.x","article-title":"The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens","volume":"135","author":"Zonneveld","year":"1996","journal-title":"Br J Dermatol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.survophthal.2018.12.001","article-title":"Vernal keratoconjunctivitis","volume":"64","author":"Singhal","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/08820538.2013.874483","article-title":"Pathogenesis of vernal keratoconjunctivitis and associated factors","volume":"30","author":"Nebbioso","year":"2015","journal-title":"Semin Ophthalmol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.eye.6700675","article-title":"Vernal keratoconjunctivitis","volume":"18","author":"Bonini","year":"2004","journal-title":"Eye (Lond)"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/aos.15212","article-title":"Prevalence of allergic sensitization with vernal keratoconjunctivitis: a systematic review with meta-analyses","volume":"101","author":"Rasmussen","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/pai.12197","article-title":"Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes","volume":"25","author":"Vichyanond","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICO.0b013e318159afbb","article-title":"Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis","volume":"27","author":"Kymionis","year":"2008","journal-title":"Cornea"},{"key":"R20-20250804","first-page":"177","article-title":"A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children","volume":"30","author":"Labcharoenwongs","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"107409","DOI":"10.1016\/j.ijscr.2022.107409","article-title":"Deep anterior lamellar limbo-keratoplasty for bilateral limbal stem cell deficiency with corneal scarring in chemical injury sequelae: two case reports","volume":"97","author":"Jain","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"106968","DOI":"10.1016\/j.ijscr.2022.106968","article-title":"Allogeneic simple limbal epithelial transplantation for bilateral limbal stem cell deficiency in chronic vernal keratoconjunctivitis: a case report","volume":"94","author":"Jain","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.14888","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/bjd.13730","article-title":"Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis","volume":"172","author":"van der Schaft","year":"2015","journal-title":"Br J Dermatol"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pde.12592","article-title":"Oral cyclosporine weekend therapy: a new maintenance therapeutic option in patients with severe atopic dermatitis","volume":"32","author":"Garrido Colmenero","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","article-title":"Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy","volume":"142","author":"Harper","year":"2000","journal-title":"Br J Dermatol"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/0301-4738.119431","article-title":"Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India","volume":"61","author":"Saboo","year":"2013","journal-title":"Indian J Ophthalmol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"e0215528","DOI":"10.1371\/journal.pone.0215528","article-title":"Prevalence of vernal keratoconjunctivitis and its associated factors among children in Gambella town, southwest Ethiopia, June 2018","volume":"14","author":"Alemayehu","year":"2019","journal-title":"PLoS One"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jtos.2019.08.011","article-title":"Allergic eye disease in children and adolescents seeking eye care in India: electronic medical records driven big data analytics report II","volume":"17","author":"Das","year":"2019","journal-title":"Ocul Surf"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2016.284","article-title":"The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on","volume":"31","author":"Dart","year":"2017","journal-title":"Eye (Lond)"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T14:02:21Z","timestamp":1754316141000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000003786","relation":{},"ISSN":["0277-3740","1536-4798"],"issn-type":[{"value":"0277-3740","type":"print"},{"value":"1536-4798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"2024-05-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}